Clinical Trial Update: Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

View source ↗

Summary

A clinical trial investigating whether the gut microbiome influences the efficacy and safety of PD-1/PD-L1 blockade in patients with resectable non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Capital Medical University | Conditions: Lung Cancer (NSCLC) | Status: NOT_YET_RECRUITING